Valuation: Electromed, Inc.

Market Cap 199M 180M 167M 150M 283M 18.74B 293M 2B 794M 10.01B 746M 730M 31.78B P/E 2027 *
16.5x
P/E 2028 * 14.5x
Enterprise Value 199M 180M 167M 150M 283M 18.74B 293M 2B 794M 10.01B 746M 730M 31.78B EV / Sales 2027 *
2.42x
EV / Sales 2028 * 2.18x
Free-Float
82.55%
Yield 2027 *
-
Yield 2028 * -
1 day-2.60%
1 week-10.49%
Current month-10.06%
1 month-11.50%
3 months-41.00%
6 months-33.37%
Current year-16.48%
1 week 23.64
Extreme 23.64
28
1 month 23.64
Extreme 23.64
28.34
Current year 23.01
Extreme 23.01
47.4
1 year 23.01
Extreme 23.01
47.4
3 years 9.81
Extreme 9.81
47.4
5 years 8.75
Extreme 8.75
47.4
10 years 3.6
Extreme 3.6
47.4
Manager TitleAgeSince
Chief Executive Officer 61 01/07/2023
Director of Finance/CFO 44 14/11/2022
Compliance Officer - 01/09/2023
Director TitleAgeSince
Chairman 70 01/07/2023
Director/Board Member 76 21/11/2014
Director/Board Member 57 15/08/2019
Date Insider Type Main position Quantity % Market Cap. Importance
9/1/26 A Free

Chief Financial Officer

15,602 0.1865%
9/1/26 A Tax

Chief Executive Officer

-2,671 0.0319%
6/30/26 A Tax

Chief Financial Officer

-674 0.0081%
Change 5-day change 1-year change 3-year change Capi.($)
-2.60%-10.49%-3.76%+131.18% 199M
+0.11%+0.79%+21.00%+52.47% 259B
+0.37%+1.20%+5.34%+14.49% 164B
+0.84%-2.03%-19.28%+52.11% 154B
+0.32%+3.72%-56.82%-17.92% 64.27B
+1.28%+4.91%+24.16%+62.87% 61.61B
+0.34%-1.59%+0.18%-11.25% 53.94B
+0.55%-0.46%+18.49%+55.86% 49.04B
-0.29%-0.72%+2.78%+73.84% 48.82B
-0.42%+0.58%+21.31%+77.93% 45.24B
Average +0.05%-0.41%+1.34%+49.16% 90B
Weighted average by Cap. +0.37%+0.57%+3.57%+40.00%

Financials

2027 *2028 *
Net sales 82.3M 74.58M 68.98M 62.24M 117M 7.76B 121M 829M 329M 4.15B 309M 302M 13.16B 91.3M 82.74M 76.53M 69.05M 130M 8.61B 135M 919M 365M 4.6B 343M 335M 14.6B
Net income 12.75M 11.55M 10.69M 9.64M 18.17M 1.2B 18.81M 128M 50.9M 642M 47.85M 46.83M 2.04B 14.75M 13.37M 12.36M 11.15M 21.02M 1.39B 21.76M 149M 58.89M 743M 55.35M 54.18M 2.36B
Net Debt - -
Projected Income Statement - Annual - Electromed, Inc.
Logo Electromed, Inc.
Electromed, Inc. develops, manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. It applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. The SmartVest Clearway is designed for comfort and convenience, so patients can readily fit therapy into their daily routines. The SmartVest System is primarily prescribed for patients with bronchiectasis, cystic fibrosis, and neuromuscular conditions such as cerebral palsy and amyotrophic lateral sclerosis. It also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.
Employees
196
Date Price Change Volume
13/11/26 $24.32 -2.60% 59,478
12/11/26 $24.97 +0.04% 123,414
11/11/26 $24.96 -8.17% 104,598
10/11/26 $27.18 +0.44% 58,260
09/11/26 $27.06 -0.40% 69,674
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Electromed, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
24.32USD
Average target price
48.50USD
Spread / Average Target
+99.42%
  1. Stock Market
  2. Stocks
  3. ELMD Stock